| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.3 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.3 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |